Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06057753

MyStroke in Chronic Stroke

This is a single-center randomized control trial assessing the impact of a personalized video-based educational platform on patients satisfaction and stroke knowledge in the context of chronic stroke.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Stroke Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Nervous System Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • History of ischemic stroke between 1 and 10 years prior to enrollment
  • Receiving outpatient stroke care at the Hospital of the University of Pennsylvania
  • At least 18 years old
  • Access to a smart phone, tablet, or computer
  • Willingness to complete 2 follow-up surveys (7 days and 90 day post-enrollment)

Exclusion criteria

  • Unwilling or unable to access the customized app with a smartphone, tablet, or computer
  • Complete dependence on caregiver for all activities of daily living
  • Stroke occurred less than 1 year or greater than 10 years prior to screening/enrollment
  • Patient has severe aphasia (score of greater than or equal to 2 on National Institutes of Health Stroke Scale item 9)

Treatment and study plan

MyStroke

Behavioral

Personalized video-based stroke education platform

Primary outcomes

  1. Patient satisfaction with stroke education (90 days)

    Time frame: 90 days

    5-point Likert-scale (Q: I am satisfied with the quality of my stroke education; Answers range from strongly disagree to strongly agree)

  2. Stroke etiology recognition (90 days)

    Time frame: 90 days

    The proportion of patients who correctly identify their stroke etiology

  3. Stroke risk factor recognition (90 days)

    Time frame: 90 days

    The proportion of patients who correctly identify at least one of their vascular risk factors

Secondary outcomes

  1. Stroke prevention medication recognition (7 days)

    Time frame: 7 days

    The proportion of patients who correctly identify their antithrombotic medications

  2. Stroke prevention medication recognition (90 days)

    Time frame: 90 days

    The proportion of patients who correctly identify their antithrombotic medications

  3. Patient satisfaction with stroke education (7 days)

    Time frame: 7 days

    5-point Likert-scale (Q: I am satisfied with the quality of my stroke education; Answers range from strongly disagree to strongly agree)

  4. Stroke etiology recognition (7 days)

    Time frame: 7 days

    The proportion of patients who correctly identify their stroke etiology

  5. Stroke risk factor recognition (7 days)

    Time frame: 7 days

    The proportion of patients who correctly identify at least one of their vascular risk factors

  6. Stroke patient education retention (SPER) survey (7 days)

    Time frame: 7 days

    total score from the 5-question SPER (scale 0-10; higher score reflects better knowledge)

  7. Stroke patient education retention (SPER) survey (90 days)

    Time frame: 90 days

    total score from the 5-question SPER (scale 0-10; higher score reflects better knowledge)

  8. EuroQOL - visual analog scale (7 days)

    Time frame: 7 days

    patient-reported quality of life score (scale 0-100; higher score reflects better self-reported quality of life)

  9. EuroQOL - visual analog scale (90 days)

    Time frame: 90 days

    patient-reported quality of life score (scale 0-100; higher score reflects better self-reported quality of life)

  10. modified Rankin Scale

    Time frame: 90 days

    Ordinal functional disability scale (score 0 - 6)

  11. Medication adherence (7 days)

    Time frame: 7 days

    total score of the Adherence Estimator (3 question survey; total score 0-36; higher score reflects higher risk of non-adherence)

  12. Medication adherence (90 days)

    Time frame: 90 days

    total score of the Adherence Estimator (3 question survey; total score 0-36; higher score reflects higher risk of non-adherence)

Sponsors and collaborators

Lead sponsor

University of Pennsylvania

Other

Registry information

Official study title

Personalized Video-based Education for Chronic Stroke Survivors: A Randomized Clinical Trial

Important dates

Study start
2023
Primary completion
2024
Study completion
2026
First posted
Sep 28, 2023
Registry last updated
Feb 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.